Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 445-890-5 | CAS number: 201290-01-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1 May 2003 to 3 June 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2002
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- -
- EC Number:
- 445-890-5
- EC Name:
- -
- Cas Number:
- 201290-01-9
- Molecular formula:
- C14H37NO2Si3
- IUPAC Name:
- 7-ethoxy-2,2,7-trimethyl-3-(trimethylsilyl)-8-oxa-3-aza-2,7-disiladecane
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at room temperature in the dark
- Stability under test conditions: stable
- Solubility and stability of the test substance in the solvent/vehicle: a vehicle trial showed that the test substance forms a clear liquid at 50% v/v in dimethylformamide (DMF).
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: The absorption of the test substance was not determined. Chemical analysis of the homogeneity, stability and purity of the test substance was not undertaken.
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: the test material was dissolved in dimethylformamide
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan UK Ltd., England
- Females (if applicable) nulliparous and non-pregnant: [not specified]
- Microbiological status of animals, when known: no data
- Age at study initiation: 8 - 12 weeks old
- Weight at study initiation: 16.5 to 22.9 g
- Housing: individually in polycarbonate cages with woodflake bedding
- Diet (e.g. ad libitum): standard laboratory rodent diet, ad libitum
- Water (e.g. ad libitum): drinking water, ad libitum
- Acclimation period: 6 days
- Indication of any skin lesions: none reported
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 2°C
- Humidity (%): 40 - 70%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- Preliminary study: 25 and 50% v/v, and 100% in DMF
Main study: 25 and 50% v/v, and 100% in DMF - No. of animals per dose:
- 4 mice per dose
- Details on study design:
- PRE-SCREEN TESTS:
One female was treated at one of three concentrations of the test substance. The mice were treated by daily application of 25 µl of appropriate concentration of the test substance to the dorsal surface of each ear for three consecutive days. The test substance was applied to the dorsal surface of each ear using an automatic micropipette. The test substance was spread over the entire dorsal surface of the ear using the tip of the pipette.
MAIN STUDY
Groups of four mice were treated at one of three concentrations of the test substance. The mice were treated by daily application of 25 µl of the appropriate concentration of the test substance to the dorsal surface of each ear for three consecutive days. The test substance was applied to the dorsal surface of each ear using an automatic micropipette. The test substance was spread over the entire dorsal surface of the ear using the tip of the pipette. A further group of four mice received the vehicle alone in the same manner. Five days following the first topical application of the test substance (day 6) all mice were injected via the tail vein with 250µl of phosphate buffered saline containing ³H-methyl thymidine giving a normal 20 µCi to each mouse. The injection into the tail vein was carried out using a plastic syringe and needle after the mouse had been heated in a warming chamber.
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: The test substance is considered to be a sensitiser if at least one concentration of the test substance results in a three-fold greater increase in ³H-methyl thymidine incorporation compared to control values (SI > 3).
OBSERVATIONS
Daily observations for clinical signs of toxicity. The ears were also examined for signs of irritation. Body weights of mice in the preliminary and main study were recorded on arrival, day 1 and prior to termination.
TERMINAL STUDIES
- Termination: 5 hours after administration of ³H-methyl thymidine on day 6 all mice were killed and the draining auricular lymph nodes excited and pooled for each experimental group. 1.0. ml of phosphate buffered saline was added to the pooled lymph nodes. The animals were then discarded and no further investigations were carried out.
- Preparation of single cell suspensions: A single cell suspension of lymph node cells (LNC) was prepared by gentle mechanical disaggregation through a stainless steel gauze. The pooled LNC were then washed, pelleted for 10 minutes and resuspended. The cells were washed twice again and resuspended in 3 ml trichloroacetic acid (TCA) following the final wash.
- Determination of incorporated ³H-methyl Thymidine: After an overnight incubation with TCA the precipitate was recovered by centrifugation and resuspended. ³H-methyl Thymidine incorporation was determined by β-scintillation counting. The proliferative response of LNC was expressed as radioactive disintegrations per minute per lymph node and as the ration of ³H-methyl Thymidine incorporation into LNC of test nodes relative to that recorded for control nodes. - Positive control substance(s):
- not specified
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 11
- Test group / Remarks:
- 25% v/v in DMF
- Key result
- Parameter:
- SI
- Value:
- 17.5
- Test group / Remarks:
- 50% v/v in DMF
- Key result
- Parameter:
- SI
- Value:
- 27.1
- Test group / Remarks:
- 100%
- Key result
- Parameter:
- EC3
- Value:
- 10.96
- Remarks on result:
- other: EC3 value was estimated based on SI data.
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA:
The test/control ratios obtained for 25, 50 and 100 % were 11.0, 17.5 and 27.1, respectively. As a test/ control ratio of 3 or more was recorded for all of the concentrations tested , the test substance was considered to have the potential to cause skin sensitisation (delayed contact hypersensitivity).
DETAILS ON STIMULATION INDEX CALCULATION: ³H-methyl Thymidine incorporation was determined by β-scintillation counting. The proliferative response of LNC was expressed as radioactive disintegrations per minute per lymph node and as the ration of ³H-methyl Thymidine incorporation into LNC of test nodes relative to that recorded for control nodes.
CLINICAL OBSERVATIONS:
- Preliminary study: No deaths occurred during the study. Post-dose wet fur around the cranial region of all the animals was observed throughout the three groups from day 1. The animals appeared normal by day 4 post-dosing. On the basis of the results, 100% was considered a suitable high dose level for the main study.
- Main study: No deaths occurred during the study period. No clinical signs of toxicity were noted in any of the test animals. Post-dose wet fur around the cranial region of all the animals was observed throughout the three groups from day 1. The animals appeared normal by day 4 post-dosing.
BODY WEIGHTS
- Preliminary study: Bodyweight loss was recorded in one animal in group 2
- Main study: The expected body weight gain was observed in all the animals.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- In the skin sensitisation study, conducted according to OECD TG 429 and in compliance with GLP, the test material, N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane, was reported to be a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.